19 Results for "

PDZ+domain

" in MedChemExpress (MCE) Product Catalog:
Products (19)

19 Results for "PDZ+domain" in MCE Product Catalog:

8
8 Publications Verification
Cat. No.: HY-P0117
CAS No.: 500992-11-0
Synonyms: Tat-NR2Bct; NA-1
Target:  

iGluR NO Synthase

Research Areas:  

Neurological Disease

Tat-NR2B9c (Tat-NR2Bct; NA-1) is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC50 values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy .
loading...
    loading...
8
8 Publications Verification
Cat. No.: HY-P0117A
CAS No.: 1834571-04-8
Synonyms: Tat-NR2Bct TFA; NA-1 TFA
Target:  

iGluR NO Synthase

Research Areas:  

Neurological Disease

Tat-NR2B9c TFA (Tat-NR2Bct TFA) is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c TFA disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC50 values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c TFA also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-117666
CAS No.: 144678-63-7
Purity:  ≥99.0%
Target:  

Wnt

Research Areas:  

Inflammation/Immunology

NSC668036 is a Dishevelled (Dvl) PDZ domain inhibitor with a Kd of 237 μM. NSC668036 blocks Wnt signaling by interrupting the Frizzled-Dvl interaction .
loading...
    loading...
Cat. No.: HY-102067
CAS No.: 294891-81-9
Target:  

Wnt

Research Areas:  

Cancer

3289-8625 is an inhibitor of the PDZ domain of Dishevelled (Dvl) protein (Kd=10.6 μM) and has an inhibitory effect on Wnt signaling. In addition, 3289-8625 can slow the growth of prostate cancer PC-3 cells (IC50=12.5 μM). 3289-8625 can be used in the study of embryonic development and cancer .
loading...
    loading...
Cat. No.: HY-117772
CAS No.: 1215849-96-9
Purity:  99.84%
Target:  

iGluR

FSC231 is a PSD‐95/DLG/ZO‐1 (PDZ) domain inhibitor of PICK1. FSC231 has analgesic effects .
loading...
    loading...
Cat. No.: HY-149204
Target:  

SDCBP

Research Areas:  

Cancer

SYNTi is a PDZ domain inhibitor targeting the syndecan/syntenin protein-protein Interaction. SYNTi exhibits an IC50 value of 400 nM and ligand efficiency (LE) value of 0.24. SYNTi can be used for breast cancer research .
loading...
    loading...
Cat. No.: HY-P10331
CAS No.: 2757292-12-7
Target:  

SDCBP

Research Areas:  

Cancer

KSL 128114, a peptide inhibitor of syntenin, binds the PDZ1 domain of syntenin with nanomolar affinity. KSL 128114 is resistant toward degradation in human plasma and mouse hepatic microsomes and displays a global PDZ domain selectivity for syntenin .
loading...
    loading...
Cat. No.: HY-P10226
CAS No.: 2717490-36-1
Target:  

Chloride Channel CFTR

Research Areas:  

Endocrinology

PGD97 is a selective cyclic peptide inhibitor against CAL/CFTR interactions, with a KD value of 6 nM towards the CAL PDZ domain for its desulfide cyclized form. PGD97 (desulfide cyclized form) has selectivity ≥ 130-fold compared to NHERF1/2 PDZ domains. PGD97 is capable of stabilizing F508del-CFTR at the cell membrane and improving CFTR function required for proper fluid homeostasis in tne lung. PGD97 can be used for the research of cystic fibrosis .
loading...
    loading...
Cat. No.: HY-P10212
CAS No.: 1786434-31-8
Synonyms: UCCB01-125
Target:  

iGluR

Research Areas:  

Neurological Disease

AVLX-125 (UCCB01-125) is a PSD-95 and PDZ domain inhibitor with Kd value of 10 nM. AVLX-125 can be used in the study of inflammatory pain .
loading...
    loading...
Cat. No.: HY-P2298
Target:  

PKC

Research Areas:  

Neurological Disease

TAT-P4-(DATC5)2 is a high-affinity peptide inhibitor of the PICK1 (protein interacting with C kinase-1) PDZ domain, with a Ki of 1.7 nM. TAT-P4-(DATC5)2 can inhibit addiction in rats .
loading...
    loading...
Cat. No.: HY-P2298A
Target:  

PKC

Research Areas:  

Neurological Disease

TAT-P4-(DATC5)2 TFA is a high-affinity peptide inhibitor of the PICK1 (protein interacting with C kinase-1) PDZ domain, with a Ki of 1.7 nM. TAT-P4-(DATC5)2 TFA can inhibit addiction in rats .
loading...
    loading...
Cat. No.: HY-184410
Research Areas:  

Neurological Disease

nNOS-PDZ-IN-1 is an orally active, blood-brain barrier-penetrant inhibitor of neuronal nitric oxide synthase-PDZ domain (nNOS-PDZ), with an IC50 of 0.76 μM and a KD of 0.55 μM. nNOS-PDZ-IN-1 binds to the nNOS-PDZ domain, occupies its binding site and disrupts its interaction with the serotonin transporter. nNOS-PDZ-IN-1 exhibits antidepressant activity without addiction potential or movement-related side effects. nNOS-PDZ-IN-1 can be used in research related to major depressive disorder .
loading...
    loading...
Cat. No.: HY-P77130
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PDZD11; PDZ Domain-Containing Protein 11; Prev. PDZK11; AIPP1; Plasma Membrane Calcium ATPase-Interacting Single-PDZ Protein; PISP; PMCA-Interacting Single-PDZ Protein; PDZ Domain Containing 11; ATPase-Interacting PDZ Protein
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-182624
CAS No.: 873841-43-1
Research Areas:  

Cancer

FJ9 is a NHERF1/PDZ inhibitor with human NHERF1 PDZ1 IC50 1540 μM, NHERF1 PDZ2 IC50 160 μM, and Frizzled-7-Dishevelled PDZ complex Ki 10 μM. FJ9 binds ligand-binding pockets of NHERF1 PDZ domains to block cognate ligand interactions, disrupts Frizzled-7-Dishevelled interactions, and down-regulates canonical Wnt signaling. FJ9 induces apoptosis in cancer cells with intact β-catenin signaling. FJ9 can be used for the research of non-small cell lung cancer, melanoma .
loading...
    loading...
Cat. No.: HY-184469
Research Areas:  

Cancer

DVL1/P-gp-IN-1 is a DVL1 inhibitor (lC50 of 0.97 μM) and a P-glycoprptein (P-gp) inhibitor. DVL1/P-gp-IN-1 specific binds to the PDZ domain of the DVL1 protein of the Wnt/β-catenin pathway and inhibition of the P-gp. DVL1/P-gp-IN-1 reduces β-catenin expression, suppresses colon cancer cells proliferation, and induces apoptosis both in vitro and in xenograft models. DVL1/P-gp-IN-1 can be used in colorectal cancer research .
loading...
    loading...
Cat. No.: HY-180197
PICK1 PDZ-IN-1 (Compound 6b) is a selective and brain-penetrant protein interacting with C kinase 1 (PICK1) PDZ domain inhibitor with a Ki of 27.73 μM. PICK1 PDZ-IN-1 can competitively inhibit the interaction between PICK1 and the GluA2 subunit of AMPA receptors. PICK1 PDZ-IN-1 can increase the survival rate of HT22 cells and primary cortical neuron cells induced by glutamate and inhibit ROS production. PICK1 PDZ-IN-1 exhibits neuroprotective effect and reduces the area of cerebral infarction. PICK1 PDZ-IN-1 can be used for the research of ischemic stroke .
loading...
    loading...
Cat. No.: HY-P76838
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CNKSR3; FLJ31349; Prev. MAGI1; Membrane Associated Guanylate Kinase, WW And PDZ Domain Containing 1; Connector Enhancer Of Kinase Suppressor Of Ras 3; Membrane Associated Guanylate Kinase Interacting Protein-Like 1; Connector Enhancer Of KSR 3; Membrane-A
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P87983
Synonyms: CAP70, NHERF3, PDZD1, PDZK1, Na(+)/H(+) exchange regulatory cofactor NHE-RF3, NHERF-3, CFTR-associated protein of 70 kDa, Na(+)/H(+) exchanger regulatory factor 3, Na/Pi cotransporter C-terminal-associated protein 1, PDZ domain-containing protein 1, Sodium-hydrogen exchanger regulatory factor 3, NaPi-Cap1

Host:  

Rabbit

Application:  

IHC-P, IHC-F, IF-Tissue, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P86953
Synonyms: A; IP : 3 antibody; AIP-3 antibody; AIP3 antibody; Atrophin 1 interacting protein 3 antibody; Atrophin-1-interacting protein 3 antibody; BAI1 associated protein 1 antibody; BAI1-associated protein 1 antibody; BAIAP 1 antibody; BAIAP1 antibody; BAP 1 antibody; A; IP : 3 antibody; AIP-3 antibody; AIP3 antibody; Atrophin 1 interacting protein 3 antibody; Atrophin-1-interacting protein 3 antibody; BAI1 associated protein 1 antibody; BAI1-associated protein 1 antibody; BAIAP 1 antibody; BAIAP1 antibody; BAP 1 antibody; BAP-1 antibody; BAP1 antibody; Gukmi1 antibody; MAGI 1 antibody; MAGI-1 antibody; MAGI1 antibody; MAGI1_HUMAN antibody; MAGI1c antibody; Membrane associated guanylate kinase inverted 1 antibody; membrane associated guanylate kinase WW and PDZ domain containing 1 antibody; Membrane-associated guanylate kinase antibody; Membrane-associated guanylate kinase inverted 1 antibody; TNRC 19 antibody; TNRC19 antibody; Trinucleotide repeat containing gene 19 antibody; Trinucleotide repeat containing gene 19 protein antibody; Trinucleotide repeat-containing gene 19 protein antibody; WW and PDZ domain-containing protein 1 antibody; WW domain containing protein 3 antibody; WW domain-containing protein 3 antibody; WWP 3 antibody; WWP3 antibody;

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
  • 1